DE60210936D1 - Polypeptid, das neutralisierende antikörper gegen hiv induziert - Google Patents
Polypeptid, das neutralisierende antikörper gegen hiv induziertInfo
- Publication number
- DE60210936D1 DE60210936D1 DE60210936T DE60210936T DE60210936D1 DE 60210936 D1 DE60210936 D1 DE 60210936D1 DE 60210936 T DE60210936 T DE 60210936T DE 60210936 T DE60210936 T DE 60210936T DE 60210936 D1 DE60210936 D1 DE 60210936D1
- Authority
- DE
- Germany
- Prior art keywords
- hiv
- polypeptide
- neutralizing antibodies
- induces neutralizing
- induces
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000003472 neutralizing effect Effects 0.000 title 1
- 101800001690 Transmembrane protein gp41 Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0100141 | 2001-01-05 | ||
FR0100141A FR2819256B1 (fr) | 2001-01-05 | 2001-01-05 | Polypeptide induisant des anticorps neutralisant le vih |
FR0100848 | 2001-01-23 | ||
FR0100848 | 2001-01-23 | ||
PCT/FR2002/000031 WO2002053587A2 (fr) | 2001-01-05 | 2002-01-04 | Polypeptide induisant des anticorps neutralisant le vih |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60210936D1 true DE60210936D1 (de) | 2006-06-01 |
DE60210936T2 DE60210936T2 (de) | 2006-10-19 |
Family
ID=26212817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60210936T Expired - Lifetime DE60210936T2 (de) | 2001-01-05 | 2002-01-04 | Polypeptid, das neutralisierende antikörper gegen hiv induziert |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1368478B1 (de) |
AT (1) | ATE324450T1 (de) |
AU (1) | AU2002229850A1 (de) |
CA (1) | CA2431881C (de) |
CY (1) | CY1105629T1 (de) |
DE (1) | DE60210936T2 (de) |
DK (1) | DK1368478T3 (de) |
ES (1) | ES2260416T3 (de) |
PT (1) | PT1368478E (de) |
WO (1) | WO2002053587A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1445614A1 (de) | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Verfahren zur in vitro Überwachung der Entwicklung von HIV Virus eines Individuums |
ES2366185T3 (es) * | 2003-04-11 | 2011-10-18 | Institut Pasteur | Vacunas de péptidos sintéticas para vih: el epítopo de cbd como un inmunógeno eficaz para provocar anticuerpos ampliamente neutralizantes contra el vih. |
CN1954217B (zh) * | 2004-02-06 | 2013-05-08 | 国立健康与医学研究所 | 衍生自gp41的多肽、含有所述多肽的疫苗组合物以及用于治疗个体HIV病毒感染的用途 |
WO2014020205A2 (es) * | 2012-07-31 | 2014-02-06 | Universidad De Granada | Inmunógenos anti-vih mejorados |
CN108997482A (zh) * | 2018-08-09 | 2018-12-14 | 东莞市朋志生物科技有限公司 | 用于检测hiv-1的合成肽 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1321165A (zh) * | 1998-08-03 | 2001-11-07 | 蒙他拿州大学 | 病毒性疾病的预防和治疗 |
AU2604200A (en) * | 1999-01-08 | 2000-07-24 | Panacos Pharmaceuticals, Inc. | Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41 |
-
2002
- 2002-01-04 AT AT02710945T patent/ATE324450T1/de active
- 2002-01-04 ES ES02710945T patent/ES2260416T3/es not_active Expired - Lifetime
- 2002-01-04 CA CA2431881A patent/CA2431881C/en not_active Expired - Fee Related
- 2002-01-04 DE DE60210936T patent/DE60210936T2/de not_active Expired - Lifetime
- 2002-01-04 EP EP02710945A patent/EP1368478B1/de not_active Expired - Lifetime
- 2002-01-04 WO PCT/FR2002/000031 patent/WO2002053587A2/fr active IP Right Grant
- 2002-01-04 PT PT02710945T patent/PT1368478E/pt unknown
- 2002-01-04 DK DK02710945T patent/DK1368478T3/da active
- 2002-01-04 AU AU2002229850A patent/AU2002229850A1/en not_active Abandoned
-
2006
- 2006-06-28 CY CY20061100881T patent/CY1105629T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK1368478T3 (da) | 2006-08-28 |
CA2431881A1 (en) | 2002-07-11 |
ATE324450T1 (de) | 2006-05-15 |
EP1368478A2 (de) | 2003-12-10 |
PT1368478E (pt) | 2006-07-31 |
ES2260416T3 (es) | 2006-11-01 |
WO2002053587A2 (fr) | 2002-07-11 |
DE60210936T2 (de) | 2006-10-19 |
WO2002053587A3 (fr) | 2003-09-25 |
CA2431881C (en) | 2011-02-22 |
CY1105629T1 (el) | 2010-12-22 |
AU2002229850A1 (en) | 2002-07-16 |
EP1368478B1 (de) | 2006-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0014282A (pt) | Vacinas | |
BR0107972A (pt) | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano | |
MXPA02007478A (es) | Vacuna contra el virus de inmunodeficiencia humana. | |
PL366579A1 (en) | Treatment of nail infections with no | |
FR2814958B1 (fr) | Composition vaccinale | |
CL2008003938A1 (es) | Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00). | |
DK1328547T3 (da) | Identifikation og modifikation af immundominante epitoper i polypeptider | |
CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
WO2005089231A3 (en) | Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide | |
DE60239682D1 (de) | Vakzine, welche gp120 zusammen mit nef und/oder tat enthält, zur immunisierung gegen hiv | |
YU68602A (sh) | Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje | |
CY1105629T1 (el) | Πολυπεπτιδιο που επαγει αντισωματα εξουδετερωσης του ηιv | |
WO2002035981A3 (en) | Methods and compositions for the treatment of human immunodeficiency virus infection | |
EA200400197A1 (ru) | Способы получения поливалентных бактериофагов для лечения бактериальных инфекций | |
CY1106200T1 (el) | Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους | |
TW200621800A (en) | Human immunodeficiency virus vaccine | |
HRP20030701A2 (en) | Natural antibodies active against hiv virus | |
AU2003255866A8 (en) | Gp41 epitope and uses thereof for the treatment of hiv infections | |
FR2819256B1 (fr) | Polypeptide induisant des anticorps neutralisant le vih | |
FR2839721B1 (fr) | Antigene polypeptidique induisant des anticorps neutralisant le vih | |
RU2001107405A (ru) | Способ повышения статокинетической устойчивости человека | |
AU2001270226A1 (en) | Tolerance and chronic hepatitis c virus | |
CY1108543T1 (el) | Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8328 | Change in the person/name/address of the agent |
Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN |
|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC |